Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Astria Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 36 | 33 | −3 |
| Shares | 7.37M | 6.09M | −1.28M (−17.3%) |
| Value | $65.2M | $32.8M | −$32.3M (−49.6%) |
New holders (5)
Institutions that held Astria Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 45,000 | $243.0K | 0.00% |
| Wolverine Trading, LLC | 12,836 | $65.0K | 0.00% |
| Millennium Management LLC | 10,259 | $55.0K | 0.00% |
| Group One Trading, L.P. | 2,300 | $12.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,958 | $11.0K | 0.00% |
Sold out (8)
Institutions that held Astria Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Commodore Capital LP | 239,270 | $2.12M |
| Acuta Capital Partners, LLC | 156,927 | $1.39M |
| Soleus Capital Management, L.P. | 112,499 | $994.0K |
| Gsa Capital Partners LLP | 24,996 | $221.0K |
| Price T Rowe Associates Inc | 11,966 | $106.0K |
| Goldman Sachs Group Inc | 11,221 | $99.0K |
| Cutler Group LP | 116 | $1.00K |
| Advisor Group Holdings, Inc. | 93 | $1.00K |